Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-76.75M
↓ 78% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-43.15M
Historical baseline
PeriodValueYoY Change
TTM$-76.75M-39.5%
2024$-55.03M-16.0%
2023$-47.43M+6.7%
2022$-50.83M-232.1%
2021$-15.30M-13.0%
2020$-13.54M-